ArticleBioorganic & medicinal chemistry letters2013

Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.

Jason D Downey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.